CoChat

Clozapine in the Treatment of Refractory Psychotic Mania

Green, Alan I., Tohen, Maricio, Patel, Jayendra K., Banov, Michael, DuRand, Curtiss, Berman, Ileana, Chang, Howard, Zarate, Carlos, Posener, Joel, Lee, Hang, Dawson, Ree, Richards, Carol, Cole, Jonathan O., Schatzberg, Alan F. · 2000 · American Journal of Psychiatry
Cited by 134

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: The efficacy of clozapine was examined in a group of patients with treatment-refractory bipolar disorder, manic type with psychotic features. METHOD: Twenty-two subjects with treatment-refractory bipolar disorder with active manic and psychotic symptoms participated in a 12-week open-label trial of clozapine. After a 2-10-day drug washout period, patients began treatment with clozapine at 25 mg/day; the dose was increased 25 mg/day (as tolerated) to a maximum level of 550 mg/day. Patients were evaluated longitudinally over the course of the study with the Brief Psychiatric Rating Scale (BPRS), the Young Mania Rating Scale, and the Clinical Global Impressions (CGI) scale. RESULTS: Fourteen of the 22 subjects in the study continued taking clozapine for at least 10 of the 12 weeks. Among the entire group, mean improvements of 56. 7%, 56.6%, and 39.1% were seen on the BPRS, Young Mania Rating Scale, and CGI, respectively. Seventeen of the 22 subjects (77.3%) experienced at least a 20% improvement in scores on all three scales. CONCLUSIONS: The findings from this open-label study, which are consistent with previous retrospective studies, case reports, and one other open-label prospective study, suggest that clozapine is an effective agent for patients with treatment-refractory psychotic mania.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.157.6.982

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 134

Metadata

Authors
Green, A. I., Tohen, M., Patel, J. K., Banov, M., DuRand, C., Berman, I., Chang, H., Zarate, C., Posener, J., Lee, H., Dawson, R., Richards, C., Cole, J. O., & Schatzberg, A. F.
Venue
American Journal of Psychiatry
Published
2000-06-01
Volume
157
Issue
6
Pages
982-986
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2138545726
Cited by
134
References
3
FWCI
6.91
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clozapine in the Treatment of Refractory Psychotic Mania. https://app.cochat.ai/papers/10.1176/appi.ajp.157.6.982
The paper
Green, A. I., Tohen, M., Patel, J. K., Banov, M., DuRand, C., Berman, I., Chang, H., Zarate, C., Posener, J., Lee, H., Dawson, R., Richards, C., Cole, J. O., & Schatzberg, A. F. (2000). Clozapine in the Treatment of Refractory Psychotic Mania. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.157.6.982

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.